Report a side effect Contact Us
  • Who We Are
    Who We Are
    EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million.
    • Overview
    • Vision, Mission & Values
    • Our History
    • Chairman Message
    • News and Media
      • Press Releases
      • Media Library
    • Sustainability & CSR
  • Manufacturing Facilities
    Manufacturing Facilities
    EIPICO is the Leading Egyptian Pharmaceutical Company, in Production, by Units. It is the Major Provider of Antibiotics, Lyophilized products and Spansule Capsules, to the Egyptian market.


    • Overview
    • Factory 1
    • Factory 2
    • Factory 3
    • Eiaco Factory
    • Eipico Plastic Factory
    • Industry Expansion
  • Science & Medicine
    Science & Medicine
    EIPICO provides High Quality Pharmaceutical Products at reasonable prices, thus assisting human healthcare improvement .
    • Products
    • Products (Alphabetical)
    • R&D and Quality
    • Global Accreditation
    • Regulatory Affairs
  • Global
    Global
    EIPICO is ranked Number 1 in Egyptian Exports of Pharmaceutical Products, capturing 29% of Egypt’s Total Exports of Pharmaceutical Products, by Value.
    • Overview
    • Our Export History
    • Eipico Destination
  • Investor Relations
    Investor Relations
    • Investor Relations
    • Annual Reports
  • EIPICO 3
    EIPICO 3
    The First Modular Biological and Biosimilar Facility in Egypt
    • EIPICO 3 (Biologicals & Biosimilars)
Manufacturing Facilities / Uniqueness / Automatic ampoules inspection

EIPICO uses State-Of-The-Art vision inspection equipment for the detection of any contaminants.
 
A gloved hand holds a vial filled with liquidEach ampoule passes parallel to testing stations, the measured values are documented in reports and charts. The system is validated, coping with 21CFR11 (Title 21 of the Code of Federal Regulations) established by the United States Food and Drug Administration (FDA) on Electronic Records and Electronic Signatures (ERES). Part 11, Which defines the criteria under which electronic records and electronic signatures are considered trustworthy, reliable, and equivalent to paper records-Audit Trail-cGMP and GAMP5.

The rejected vials/ampoules are then transferred to a rejection station from where they are ejected out of the machine. The correct vials/ampoules are accepted and transferred to the collection station where they are collected by a collection tray.






 Find out more  


Strile Products Area

Are areas that have HEPA filtration to remove particles from the air. They are used for manufacturing where high levels of cleanliness and sterility are required.

Read more




EIPICO Opthalmology 

EIPICO is ranked Number 1 in the Egyptian Ophthalmic Market, by Units.

Read more




Primary Packaging Materials 

EIPICO focuses on its products quality, hence holding product filling and packaging process inhouse is a corner stone of delivering products of high-quality standards to the community.

Read more






WE ARE EIPICO

EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million, currently raised to EGP 1500 Million.

Quick Links

  • EIPICO 3
  • News
  • Products
  • Global accreditation
  • Global
  • Investor relations

Contact Us

EIPICO, Tenth of Ramadan City - 1st Industrial Zone B1, Egypt.

Telephone : +20554499199
Fax : +20554499306

eipico@eipico.com.eg

Back to top
Powered by EIPICO Team
     Visitors Count : 1364467